合并颈总动脉介入增加无症状颈动脉支架术后卒中和死亡风险
基于VQI 2005-2020年数据,18,886条颈动脉支架置入中809条为串联病变(颈总动脉+颈内动脉)。症状性患者无显著差异。
要点
- 无症状颈动脉狭窄行CAS时,同期处理颈总动脉病变使围术期卒中/死亡风险近乎翻倍。
- 症状性患者串联病变支架置入未显示卒中/死亡风险显著增加。
- 无症状患者应尽可能避免同期颈总动脉病变的血管内治疗。
核心结论
- 无症状患者中,颈总动脉病变联合CAS使围术期卒中/死亡风险近乎翻倍,应尽可能避免。
- 症状性患者中,串联病变治疗未与卒中/死亡风险增加相关。
研究设计与样本
- 回顾性队列研究,查询Vascular Quality Initiative数据库2005-2020年颈动脉支架置入数据。
- 共纳入18,886条颈动脉(18,441例患者),按症状状态分层,比较孤立病变与串联病变(颈总动脉+颈内动脉)。
临床怎么用
- 对无症状颈动脉狭窄患者制定CAS策略时,应评估是否合并需同期处理的颈总动脉病变,并优先避免同期介入以降低围术期卒中/死亡风险。
- 对症状性串联病变患者,同期颈总动脉介入未显示额外风险,但仍需个体化评估。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A recent review of Vascular Study Group of New England data suggested that simultaneous endovascular treatment of tandem carotid lesions (TCAL: common carotid artery + internal carotid artery) is associated with a fourfold increase in perioperative neurologic events and death. However, given the small cohort, the effect of symptomatic status could not be evaluated. This study sought to determine the risk of simultaneous TCAL stenting in cohorts stratified by symptom status. METHODS: Vascular Quality Initiative data (2005-2020) were queried for carotid stenting procedures (CAS). Emergent and bilateral procedures, patients with prior ipsilateral CAS, internal carotid artery lesions with stenosis <50%, and hybrid transcarotid procedures were excluded. The cohort was stratified by symptomatic status. The primary outcome was the composite of perioperative stroke and death. Predictors of stroke/death were determined with multivariable logistic regression for symptomatic and asymptomatic patients with TCAL forced into the models. RESULTS: There were 18,886 carotid arteries stented (18,441 patients): 18,077 (96%) with isolated carotid artery lesions and 809 (4%) with TCAL. Mean age was 70.0 ± 9.7. Symptomatic lesions were present in 58.9% of cases (isolated carotid artery lesions: 59.1% vs TCAL: 52.5%; P < .001). More TCAL arteries had a prior carotid endarterectomy (38.3% vs 23.8%; P < .001). TCAL had a higher perioperative stroke/death (3.4% vs 1.8%; P = .026) for asymptomatic lesions, but not symptomatic lesions (4.5% vs 3.7%; P = .41). TCAL were independently associated with stroke/death in asymptomatic patients (odds ratio, 1.85; 95% confidence interval, 1.03-3.33; P = .039) but not symptomatic patients (odds ratio, 1.22; 95% confidence interval, 0.76-1.97; P = .42). CONCLUSIONS: The addition of endovascular treatment of common carotid artery lesions with CAS is associated with almost double the risk of perioperative stroke/death in asymptomatic patients and should be avoided if possible. Treatment of TCAL is not associated with an increased risk of stroke/death for symptomatic lesions.
引用
- DeCarlo C, Tanious A, Boitano LT, et al. Addition of common carotid intervention increases the risk of stroke and death after carotid artery stenting for asymptomatic patients. J Vasc Surg. 2021. PMID: 34019994. doi:10.1016/j.jvs.2021.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。